Market Signals

TRUMP’S CHINA RIVALRY AND “AI RACE” DELUSION MAY ENDANGER US, EXPERTS SAY - ARSTECHNICA

WHITE HOUSE DENIES REPORT OF 90-DAY US DIESEL EXPORT BAN - MINT

OPENING A NEW PARADIGM FOR AIDC CONSTRUCTION, AN IN-DEPTH BREAKDOWN OF HUAWEI'S WORLD'S FIRST 3D DATA CENTER - ZHIDX

Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer

HSBC targets younger workers with entry-level hiring drive

3 THINGS TO KNOW ABOUT RISING DIESEL PRICES AND HOW THEY AFFECT YOU - PBS

AI FIRM LEADERS TELL UN SECURITY COUNCIL THAT IT COULD BE A RISK TO ALL HUMANITY - PBS

SEN. BERNIE SANDERS UNVEILS BILL TO BAN ARTIFICIAL SUPERINTELLIGENCE AND CREATE DEPARTMENT OF AI - PBS

MCDONALD’S IS MAKING A HISTORIC BET ON CHICKEN — AND AI — TO BRING BACK CUSTOMERS - MARKETWATCH

Is Roche Holding (SWX:ROP) Undervalued Following Its Phase 3 IgA Nephropathy Win?

BP upgraded at J.P. Morgan after lagging rivals for years; TotalEnergies cut to Neutral

DOJ DEFENDS TRUMP MEDIA BAN: ‘ACCESS TO THE WHITE HOUSE IS A PRIVILEGE’ - GUARDIAN

A DIESEL EXPORT BAN COULD BACKFIRE — HERE’S WHY - MARKETWATCH

WATCH: IRANIAN PRESIDENT PEZESHKIAN ADDRESSES 2026 UN GENERAL ASSEMBLY - PBS

THESE STOCKS ARE THE ‘FOUR HORSEMEN OF AI’ — AND THEY’RE NOT THE ONES YOU’D THINK - MARKETWATCH

THE AI-INFRASTRUCTURE TRADE IS STILL NOT OVER, SAYS THIS TOP-PERFORMING FUND MANAGER. HERE’S WHERE HE’S INVESTING. - MARKETWATCH

AI DRONE MAKER HITS $6.4 BILLION VALUATION AS UKRAINE WAR SPURS DEFENSE TECH - CNBC

BlueCollar Cloud Announces Platinum Sponsorship of SuiteWorld 2026

SENIOR NATO COMMANDER WARNS PUTIN IS BECOMING MORE CAVALIER AND OPEN TO RISK AS UKRAINE WAR DRAGS ON

CLAUDE OPUS 5.5 STRIKES SUDDENLY! 680,000 LINES OF CODE MIGRATED IN ONE DAY, API PRICE CUT BY 20% - QBITAI

AFTER GPT-6 ASTRA'S 3D GENERATION WENT VIRAL, THE COMPETITIVE RULES FOR 3D GENERATION HAVE CHANGED. - QBITAI

ALIBABA'S QWEN AI PLATFORM FULLY UPGRADES ITS MODEL SERVICES, AGENT SERVICES, AND AI APPLICATIONS - QBITAI

Ripple Pioneer Returns to SEC Case After Spotting Familiar Tactics Outside Crypto

Capitalize on Breakthrough Therapy Designation Shifts: Benchmark Pfizer, Roche, Novartis, Merck and AstraZeneca to Accelerate Approvals, Defend Pipeli

INNOVAGE PRICES 10M SHARE SECONDARY OFFERING AT $9.25 - SEEKINGALPHA

TAMIL NADU BJP LEADER ANANTHAN AYYASAMY BACKS IIT BOMBAY PROFESSOR SURYANARAYANA DOOLLA, OPPOSES SC/ST ACT MISUSE; RECEIVES OVERWHELMING SUPPORT ONLIN

Alibaba Shares Jump After Unveiling New AI Chip

TRUMP SAYS HE SUPPORTS U.S. DIESEL EXPORT BAN; BESSENT SAYS STUDYING FEASIBILITY - SEEKINGALPHA

ANTHROPIC MAKES A BIG MOVE LATE AT NIGHT: CLAUDE OPUS 5.5 LAUNCHES, TASK COSTS DROP SHARPLY BY 40% - ZHIDX

2 MAGNIFICENT QUANTUM COMPUTING STOCKS TO BUY AND HOLD FOR 10 YEARS

RUSSIA AND UKRAINE TRADE STRIKES AHEAD OF ZELENSKYY'S MEETING WITH TRUMP - PBS

TRUMP SAYS HE BACKS DIESEL EXPORT BAN TO CURB SOARING ENERGY COSTS - GUARDIAN

HERE'S WHO WE KNOW IS GOING TO THE TRUMP-XI DINNER SO FAR - CNBC

LIVE MAP: TRACK THE PATH OF HURRICANE POLO - PBS

U.S. M2 Money Supply Recently Grew at the Fastest Pace Seen in 3 Years. It Could Be an Ominous Sign With Inflation at 3.4%.

Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity

MUSE, META'S EXTRAORDINARILY PRIVILEGED AI ASSISTANT, HAS A SERIOUS 0-DAY - ARSTECHNICA

META’S STOCK IS ENJOYING ITS BEST MONTH IN 13 YEARS THANKS TO THE COMPANY’S HOT NEW AI ASSISTANT - MARKETWATCH

How Paramount triumphed over state AGs in antitrust settlement

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicin

EXCLUSIVE: DEEPSEEK TO BRIEF UN SECURITY COUNCIL ON AI THIS WEEK, SOURCES SAY - REUTERS - GNEWS

ALIBABA'S LATEST IMAGE MODEL GOES OPEN SOURCE! THE VISUAL GENERATION PART IS ONLY 7B, CAPABLE OF GENERATING TRANSPARENT IMAGES AND EDITING IMAGES. - Z

Alibaba Group Holding (BABA) Could Be 52% Undervalued After AI Chip And Cloud Push

TELL HN: CLAUDE CODE JUST ACCEPTED AND SIGNED A CONTRACT FOR ME. WITHOUT ASKING - HN

CNBC'S THE CHINA CONNECTION NEWSLETTER: FIVE THINGS TO WATCH FOR THE TRUMP-XI SUMMIT - CNBC

Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move

ZHIPU OPEN-SOURCES ZCODE AFTER DATA DISPUTE AND PLANS NO-RETENTION CONTROLS FOR MAAS - TECHNODE

Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher

Novo Nordisk (CPSE:NOVO B) Stock Still Looks Like A Bargain Despite 52% Slide

ASML (ASML) Surpasses Market Returns: Some Facts Worth Knowing